Stock listing
Bora Pharmaceuticals Co Ltd
Selected listing: 6472 · TWSE · TWD · TW
Bora Pharmaceuticals Co Ltd (TWSE:6472), Health Technology. Latest release Sep 30, 2026: UPSHER-SMITH LAUNCHES FLUVOXAMINE MALEATE EXTENDED-RELEASE CAPSULES.
- Ticker
- TWSE:6472
- Asset type
- Stock
- Sector
- Health Technology
- Industry
- Pharmaceuticals: Other
- Exchange
- TWSE
- Currency
- TWD
About Bora Pharmaceuticals Co Ltd
The company operates in the pharmaceutical sector, focusing on providing high-quality healthcare solutions. Bora Pharmaceuticals is committed to innovation and excellence in its products and services.
Latest news from Bora Pharmaceuticals Co Ltd
UPSHER-SMITH LAUNCHES FLUVOXAMINE MALEATE EXTENDED-RELEASE CAPSULES
September 30, 2026
Insilico Medicine and Bora Pharmaceuticals Announce Strategic Alliance for AI-Driven Drug Discovery and Development
July 13, 2026
Bora Pharmaceuticals : Announcement on the Company's resolution on cash dividend date（correction and additional Information on Items 12 to 16）
July 6, 2026
Bora Pharmaceuticals Completes Acquisition of MacroGenics' Rockville Manufacturing Operations
July 2, 2026
UPSHER-SMITH EXPANDS KYMBEE™ (DEFLAZACORT) FAMILY OF PRODUCTS WITH LAUNCH OF ORAL SUSPENSION FOR THE TREATMENT OF DUCHENNE MUSCULAR DYSTROPHY
June 23, 2026
Research Bora Pharmaceuticals Co Ltd
Bora Pharmaceuticals Co Ltd company profile
View the public company page for Bora Pharmaceuticals Co Ltd on 6ix.
Bora Pharmaceuticals Co Ltd news
Read company news and market updates connected to Bora Pharmaceuticals Co Ltd.
Bora Pharmaceuticals Co Ltd investor events
Find investor webinars, events, and replay context for Bora Pharmaceuticals Co Ltd.